Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2003BMJOpen Access

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials

View Full Paper
Ask AI
Bookmark
Share

Authors

DAD. AduUniversity of Ghana

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

D. Adu (2003) studied this question.

synapsesocial.com/papers/6a82fb229ee9542cd6efdc41https://doi.org/10.1136/bmj.326.7393.789
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation122003 · 138 citations
  2. 2A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,22001 · 144 citations
  3. 3THE IMPACT OF AN ACUTE REJECTION EPISODE ON LONG-TERM RENAL ALLOGRAFT SURVIVAL (t1/2)1,21994 · 447 citations
  4. 4Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows1976 · 2,505 citations
  5. 5IMPACT OF ACUTE REJECTION THERAPY ON INFECTIONS AND MALIGNANCIES IN RENAL TRANSPLANT RECIPIENTS1999 · 92 citations